Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Seneta’s Votiro sees 95% increase in renewals as organisations scramble to upgrade their cybersecurity
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Seneta’s Votiro sees 95% increase in renewals as organisations scramble to upgrade their cybersecurity
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Seneta’s Votiro sees 95% increase in renewals as organisations scramble to upgrade their cybersecurity
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Seneta’s Votiro sees 95% increase in renewals as organisations scramble to upgrade their cybersecurity
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Seneta’s Votiro sees 95% increase in renewals as organisations scramble to upgrade their cybersecurity
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Woolworths secures majority of Quantium with $223m investment into data science
    • News

    Woolworths secures majority of Quantium with $223m investment into data science

    Having realised the incredible savings made from the mass-adoption of self-service checkouts, Woolworths (ASX: WOW) could soon have an array of other automation-driven initiatives having secured the controlling interest of data science company Quantium for $223 million. The investment will increase Woolworth’s existing shareholding from 47% to 75% following a hugely successful partnership where Quantium’s

    Read More
    Public
  • Could Creso’s psychedelics solve Australia’s $10.6 billion problem?
    • News

    Could Creso’s psychedelics solve Australia’s $10.6 billion problem?

    According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime. Treatment is somewhat limited to prescription medications and psychotherapy. However, the current mental health crisis has seen researchers and practitioners alike wondering- is there a better way to approach these frighteningly common conditions? Enter psychedelics,

    Read More
    Public
  • Uscom hits jackpot with China approval for hypertension monitor
    • News

    Uscom hits jackpot with China approval for hypertension monitor

    More than 230 million adults in China suffering from hypertension, a modifiable risk factor, will be able to reduce their risk of heart attack now that medtech company Uscom (ASX: UCM) has had the BP+ device approved for sale by Chinese regulators. Installed on the International Space Station, the BP+ is a patent-protected device that

    Read More
    Public
  • Atlanta Falcons turn to Australians to solve lead-blowing woes
    • News

    Atlanta Falcons turn to Australians to solve lead-blowing woes

    While Australian influence on the field of America’s National Football League (NFL) is growing, the bigger influence is coming off the field with sports tech and data analytics company Catapult (ASX: CAT) contracted by all 32 teams in the league now that the Atlanta Falcons are sick of losing, and have signed up.  The Falcons,

    Read More
    Public
  • Millenials get happy! Alterra is making your smashed avo dreams come true
    • News

    Millenials get happy! Alterra is making your smashed avo dreams come true

    Progressing their next-gen 300-hectare avocado project in Western Australia, sustainable agriculture specialist Alterra (ASX:1AG) could soon be extending the live-at-home lives of millenials that continue to prioritise smashed avo cafe breakfasts ahead of financial independence. The Company has released an update today on the progress of their flagship 300-hectare avocado project. The Carpenters Project, located

    Read More
    Public
  • Qantas boss pumped for NZ bubble despite $11 billion loss of revenue
    • News

    Qantas boss pumped for NZ bubble despite $11 billion loss of revenue

    News of the international travel bubble between Australia and New Zealand is music to the ears of Qantas (ASX: QAN) CEO Alan Joyce, who has probably endured the toughest gig amongst top executives having had to navigate $11 billion in lost revenue through no fault of their own. While the airfares will be one way

    Read More
    Public
  • Pharmaxis streamlines operations with $2m sale of Russian distribution rights
    • News

    Pharmaxis streamlines operations with $2m sale of Russian distribution rights

    Streamlining operations to focus on the most profitable side of their pharmaceuticals manufacturing business, Pharmaxis (ASX: PXS) has shored up its cash position via the sale of distribution rights in Russia for their cystic fibrosis treatment which is gathering international momentum. The deal will send exclusive distribution rights in Russia to specialty company GEN İlaç

    Read More
    Public
  • The rising BNPL star giving Afterpay a run for their money
    • News

    The rising BNPL star giving Afterpay a run for their money

    Zip Co (ASX: Z1P) is nipping at the heels of Australian BNPL leader Afterpay (ASX: APT), based on today’s announcement of their Q3 results. Despite the pandemic, Zip has managed to maintain momentum and deliver strong results across Australian, New Zealand, UK and US markets bolstering itself as one of the fastest growing BNPL leaders.

    Read More
    Public
  • Universal Biosensors enters collaboration to diagnose cancer from a finger prick
    • News

    Universal Biosensors enters collaboration to diagnose cancer from a finger prick

    Life expectancy rates following the diagnosis of cancer could soon be significantly improved through early detection if biotech company Universal Biosensors (ASX: UBI) is successful in their newest research collaboration aiming to instantly identify cancer cells from a simple finger prick.  The research project will be part of an exclusive collaboration between Deakin University’s Institute

    Read More
    Public
  • How Bitcoin is assisting this ASX listed eCommerce player
    • News

    How Bitcoin is assisting this ASX listed eCommerce player

    IT and consumer electronics retailer Harris Technology (ASX: HT8) has delivered a whopping 206% increase in quarterly year-on-year revenue partially assisted by the demand of high-end gaming graphic cards used for Bitcoin mining. For the quarter ended 31 March 2021, Harris Technology has reported $10.4 million (unaudited) in sales revenue which would represent a 206%

    Read More
    Public
  • «
  • ‹
  • 247
  • 248
  • 249
  • 250
  • 251
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.